-
Patient with advanced non-small-cell lung cancerpresenting an exceptional response to targeted therapipies
Thonnard A.S. , Bosquée L. , Corhay J-L.
Rev Med Liege 2011, 66(3),121-125Abstract : Advanced non-small-cell lung cancers are diseases of late diagnosis with bad prognosis. Conventional chemotherapies are not very efficient. Over the last years, many research works have been performed in this way to improve prognosis. Targeted therapies seem promising. They were notably developed against epithelial growth factor receptors and tumoral angiogenesis. We report here the clinical history of a patient with an advanced non-small-cell lung cancer presenting an exceptional response to small-molecule tyrosine kinase inhibitors.
